| Literature DB >> 35268470 |
Yeon Jee Lee1, Dong-Eun Lee2, Jaekyung Bae3, Hyeong In Ha4, Myong Cheol Lim1,5,6,7.
Abstract
We aim to analyze the surgical outcomes and learning curve of single-site robot-assisted hysterectomy. This was a retrospective cohort study from a single academic medical center. A total of 123 patients who underwent single-site robotic surgery for gynecologic disease were enrolled. Gynecologic surgeries were performed by a single surgeon using single-site robot-assisted hysterectomy. The median age of enrolled patients was 49 years (range: 30-74 years). The median operation time was 131 min (range: 59-502 min) and the median docking time was 3 min (range: 1-10 min). In addition, the median console time was 76 min (range: 29-465 min). The cumulative sum (CUSUM) graph for total operation time indicated an initial decrease at case 41, generating 3 distinct performance phases: learning (n = 41 initial cases), competence (n = 54 middle cases), and mastery (n = 28 final cases). There was one case conversion to open surgery due to the difficulty in securing the field of view because of a 16-cm bulky mass protruding from the left pelvic wall. No patients required a transfusion and two complications including vaginal cuff dehiscence were identified. The single-site robot-assisted hysterectomy is a safe and feasible procedure. The learning curve consisted of 41 cases to significantly decrease the total operation time.Entities:
Keywords: CUSUM graph; hysterectomy; learning curve; robotic surgery
Year: 2022 PMID: 35268470 PMCID: PMC8911377 DOI: 10.3390/jcm11051378
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Single-site placement for robotic surgery. (A) Before docking. (B) After docking.
Characteristics of patients who were underwent single-port robotic surgery.
| Total | Phase 1 | Phase 2 | Phase 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ||||||
|
| % |
| % |
| % |
| % | ||
| Age (yr), median (range) | 49 (30–74) | 50 (35–68) | 48.5 (34–67) | 50 (30–74) | 0.8960 * | ||||
| BMI (kg/m2), median (range) | 23.2 (18.0–34.9) | 22.9 (18.0–34.9) | 23 (18.0–32.6) | 24.4 (18.6–29.8) | 0.2640 * | ||||
| Parity | 106 | 86.2 | 34 | 82.9 | 50 | 92.6 | 22 | 78.6 | 0.1662 † |
| Menopause | 48 | 39 | 16 | 39 | 20 | 37 | 12 | 42.9 | 0.8770 † |
| Chronic illness | 45 | 36.6 | 12 | 29.3 | 17 | 31.5 | 16 | 57.1 | 0.0359 † |
| Vaginal delivery | 73 | 59.4 | 24 | 58.5 | 32 | 59.3 | 17 | 60.7 | 0.9836 † |
| Previous cesarean section | 38 | 30.9 | 13 | 31.7 | 19 | 35.2 | 6 | 21.4 | 0.4375 † |
| Previous abdominal surgery | 47 | 38.2 | 11 | 26.8 | 19 | 35.2 | 17 | 60.7 | 0.0145 † |
| ASA classification | <0.0001 ‡ | ||||||||
| I | 74 | 60.2 | 33 | 80.5 | 37 | 68.5 | 4 | 14.3 | |
| II | 48 | 39 | 8 | 19.5 | 17 | 31.5 | 23 | 82.1 | |
| III | 1 | 0.8 | 0 | 0 | 0 | 0 | 1 | 3.6 | |
| Indication of surgery | 0.5755 ‡ | ||||||||
| Adenomyosis | 16 | 13 | 6 | 14.6 | 8 | 14.8 | 2 | 7.1 | |
| Myoma | 56 | 45.5 | 20 | 48.8 | 26 | 48.2 | 10 | 35.7 | |
| Adenomyosis and myoma | 27 | 22 | 8 | 19.5 | 12 | 22.2 | 7 | 25 | |
| Endometrial hyperplasia | 1 | 0.8 | 0 | 0 | 0 | 0 | 1 | 3.6 | |
| Malignancy | 3 | 2.4 | 0 | 0 | 1 | 1.9 | 2 | 7.1 | |
| Ovarian cyst | 20 | 16.3 | 7 | 17.1 | 7 | 13 | 6 | 21.4 | |
| Concomitant procedure | |||||||||
| Adnexectomy | 0.9466 ‡ | ||||||||
| USO | 2 | 1.6 | 1 | 2.4 | 1 | 1.9 | 0 | 0 | |
| BSO | 64 | 52 | 23 | 56.1 | 27 | 50 | 14 | 50 | |
| Ovarian cystectomy | 8 | 6.5 | 3 | 7.3 | 4 | 7.4 | 1 | 3.6 | 0.8078 ‡ |
| Peritonectomy | 2 | 1.6 | 1 | 2.4 | 1 | 1.9 | 0 | 0 | 1.0000 ‡ |
| Adhesiolysis | 61 | 49.6 | 23 | 56.1 | 28 | 51.9 | 10 | 35.7 | 0.2275 † |
| Pelvic washing cytology | 122 | 99.2 | 40 | 97.6 | 54 | 100 | 28 | 100 | 0.5610 ‡ |
| Pelvic LND | 19 | 15.5 | 6 | 14.6 | 9 | 16.7 | 4 | 14.3 | 0.9459 † |
| Para-aortic LND | 1 | 0.8 | 0 | 0 | 1 | 1.9 | 0 | 0 | 1.0000 ‡ |
* Kruskal—Wallis test, † Chi-squared test, ‡ Fisher’s exact test. Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; BSO, bilateral salpingo-oophorectomy; LND, lymph node dissection; USO, unilateral salpingo-oophorectomy.
Surgical outcomes of single-port robotic surgery.
| Total | Phase 1 | Phase 2 | Phase 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ||||||
|
| % |
| % |
| % |
| % | ||
| Uterine mass size (cm), median (range) | 6.8 (0–26) | 5 (0.5–13.5) | 7.5 (0–22) | 9.75 (6–26) | <0.0001 * | ||||
| Operation time (min), median (range) | 131 (59–502) | 140 (73–274) | 130.5 (59–502) | 129 (83–208) | 0.6943 * | ||||
| Docking time (min), median (range) | 3 (1–10) | 3 (1–6) | 2 (1–10) | 3 (1–10) | 0.0242 * | ||||
| Console time (min), median (range) | 76 (29–465) | 77 (41–208) | 77 (29–465) | 74 (40–147) | 0.4023 * | ||||
| Adnexal surgery | 66 | 53.7 | 24 | 58.5 | 28 | 51.9 | 14 | 50 | 0.7357 † |
| EBL (mL) | 10 (5–500) | 20 (5–160) | 10 (5–480) | 5 (5–500) | 0.0007 * | ||||
| Uterus weight (g) | 180 (44–1230) | 200.5 (50–730) | 180 (44–1230) | 159 (45–580) | 0.2371 * | ||||
| NA = 8 | NA = 5 | NA = 3 | |||||||
| Postoperative hospital stay (days), median (range) | 4 (3–10) | 4 (3–6) | 4 (3–10) | 4 (3–7) | 0.7595 * | ||||
| Conversion | |||||||||
| Open laparotomy | 1 | 0.8 | 0 | 0 | 0 | 0 | 1 | 3.6 | 0.2276 ‡ |
| Drain insertion | 9 | 7.3 | 7 | 17.1 | 1 | 1.9 | 1 | 3.6 | 0.0187 ‡ |
| Readmission | 5 | 4.1 | 1 | 2.4 | 3 | 5.6 | 1 | 3.6 | 0.8479 ‡ |
| Complications | |||||||||
| Immediate complication | |||||||||
| Abdominal pain | 3 | 2.4 | 0 | 0 | 3 | 5.6 | 0 | 0 | 0.3225 ‡ |
| Postoperative pain (NRS) | |||||||||
| Use of additional pain killer: NSAIDs, Opioids | 90 | 73.2 | 33 | 80.5 | 39 | 72.2 | 18 | 64.3 | 0.3216 † |
| PCA use on operation day | 11 | 8.9 | 8 | 19.5 | 3 | 5.6 | 0 | 0 | 0.0119 ‡ |
| PCA use after 24 h | 5 | 4.1 | 4 | 9.8 | 1 | 1.9 | 0 | 0 | 0.1188 ‡ |
| Pain killer not used | 28 | 22.8 | 4 | 9.8 | 14 | 25.9 | 10 | 35.7 | 0.0314 † |
| Delayed postoperative complication | 0.0296 ‡ | ||||||||
| Umbilical incisional hernias | 3 | 2.4 | 0 | 0 | 3 | 5.6 | 0 | 0 | |
| Vaginal cuff dehiscence | 2 | 1.6 | 0 | 0 | 0 | 0 | 2 | 7.1 | |
* Kruskal—Wallis test, † Chi-squared test, ‡ Fisher’s exact test. Abbreviations: EBL, estimated blood loss; NRS, numerical rating scale; PCA, patient-controlled analgesia.
Figure 2Cumulative sum (CUSUM) chart of single-site robotic surgery. (A) Operation time. (B) Docking time. (C) Console time.
Identification of factors affecting operation time using a linear regression model.
| Univariable | Multivariable ( | ||||||
|---|---|---|---|---|---|---|---|
| Beta | SE | Beta | SE | ||||
| Age (yr) | −1.10 | 0.66 | 0.1012 | ||||
| BMI (kg/m2) | 2.44 | 1.48 | 0.1015 | ||||
| Uterus weight (g) | Missing = 8 | 0.19 | 0.02 | <0.0001 | 0.18 | 0.02 | <0.0001 |
| Parity | No | 1(ref) | 1(ref) | ||||
| Yes | −51.19 | 14.74 | 0.0007 | −36.49 | 12.42 | 0.0040 | |
| Menopause | No | 1(ref) | |||||
| Yes | −16.03 | 10.84 | 0.1416 | ||||
| Chronic illness | No | 1(ref) | |||||
| Yes | −11.75 | 11.02 | 0.2883 | ||||
| Vaginal delivery | No | 1(ref) | |||||
| Yes | −6.26 | 10.84 | 0.5646 | ||||
| Previous cesarean section | No | 1(ref) | |||||
| Yes | −15.87 | 11.45 | 0.1683 | ||||
| Previous abdominal surgery | No | 1(ref) | |||||
| Yes | −22.57 | 10.78 | 0.0385 | ||||
| ASA classification | I | 1(ref) | |||||
| II, III | −9.95 | 10.86 | 0.3614 | ||||
| Adnexectomy | None | 1(ref) | |||||
| USO, BSO | −15.47 | 10.60 | 0.1471 | ||||
| Ovarian cystectomy | No | 1(ref) | |||||
| Yes | 19.05 | 21.56 | 0.3788 | ||||
| Other (Peritonectomy, Adhesiolysis, | No | 1(ref) | |||||
| Pelvic LND, Para-aortic LND) | Yes | 19.63 | 10.62 | 0.0671 | |||
Figure 3Single-site robot-assisted hysterectomy for massive mass removal. (A) The massive fibroid uterus fills the abdominal cavity. (B) Careful coagulation of round ligament using the bipolar grasper by rotation.